In the TCGA dataset, high CTU2 expression was associated with higher TIDE scores, particularly in ACC, BLCA, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), HNSC, ESCA, KIRC, LIHC, LGG, PCPG, SKCM, STAD, THCA, UCEC, and KIRP (Figure 6C, Supplementary Figure S6). The gene discussed is CTU2; the disease is bladder transitional cell carcinoma.